Mundipharma
- J02 - Antimicóticos de uso sistémico
- REZZAYO powder for solution for infusion 200 mg
- L03 - Inmunoestimulantes
- PELMEG EN SERINGUE PRÉREMPLIE solution for injection 6 mg
- N02 - Analgésicos
- MOSCONTIN prolonged-release tablet 10 mg
- MOSCONTIN prolonged-release tablet 100 mg
- MOSCONTIN prolonged-release tablet 200 mg
- MOSCONTIN prolonged-release tablet 30 mg
- MOSCONTIN prolonged-release tablet 60 mg
- OXSYNIA LP prolonged-release tablet 10 mg+5 mg
- OXSYNIA LP prolonged-release tablet 15 mg+7.5 mg
- OXSYNIA LP prolonged-release tablet 2.5 mg+1.25 mg
- OXSYNIA LP prolonged-release tablet 20 mg+10 mg
- OXSYNIA LP prolonged-release tablet 30 mg+15 mg
- OXSYNIA LP prolonged-release tablet 40 mg+20 mg
- OXSYNIA LP prolonged-release tablet 5 mg+2.5 mg
- OXYCONTIN LP prolonged-release tablet 10 mg
- OXYCONTIN LP prolonged-release tablet 120 mg
- OXYCONTIN LP prolonged-release tablet 15 mg
- OXYCONTIN LP prolonged-release tablet 20 mg
- OXYCONTIN LP prolonged-release tablet 30 mg
- OXYCONTIN LP prolonged-release tablet 40 mg
- OXYCONTIN LP prolonged-release tablet 5 mg
- OXYCONTIN LP prolonged-release tablet 60 mg
- OXYCONTIN LP prolonged-release tablet 80 mg
- OXYNORM capsule, hard 10 mg
- OXYNORM capsule, hard 20 mg
- OXYNORM capsule, hard 5 mg
- OXYNORM oral solution 10 mg/ml
- OXYNORM solution for injection 10 mg/ml
- OXYNORM solution for injection 50 mg/ml
- OXYNORMORO orodispersible tablet 10 mg
- OXYNORMORO orodispersible tablet 20 mg
- OXYNORMORO orodispersible tablet 5 mg
- SEVREDOL film-coated tablet 10 mg
- SEVREDOL film-coated tablet 20 mg
- SOPHIDONE LP prolonged-release capsule, hard 16 mg
- SOPHIDONE LP prolonged-release capsule, hard 24 mg
- SOPHIDONE LP prolonged-release capsule, hard 4 mg
- SOPHIDONE LP prolonged-release capsule, hard 8 mg
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- FLUTIFORM pressurised inhalation, suspension 125 µg/dose+5 µg/dose
- FLUTIFORM pressurised inhalation, suspension 50 µg/dose+5 µg/dose
- V03 - Todos los demás preparados terapéuticos
- NYXOID EN RÉCIPIENT UNIDOSE nasal spray, solution 1.8 mg